Report Combined TCR Repertoire Proﬁles and Blood Cell Phenotypes Predict Melanoma Patient Response toPersonalized Neoantigen Therapy plus Anti-PD-1 Graphical Abstract Highlights dPre-treatment blood-based factors predict response to immunotherapy dTCR repertoire clonality and stability associate with improvedclinical outcomes dBaseline T and B cell memory phenotypes associate withimproved clinical outcomes dCombined baseline TCR repertoire and PBMC phenotypespredict immunotherapy responseAuthors Asaf Poran, Julian Scherer,Meghan E. Bushway, ...,Richard B.